U.S. FTC requires Amneal and Impax to divest rights to 10 generic drugs

U.S. FTC requires Amneal and Impax to divest rights to 10 generic drugs

Submitted by admin on April 29, 2018 - 12:14pm
Source: 
Reuters
News Tags: 
FTV
Impax Laboratories
Amneal
generics
M&A
Headline: 
U.S. FTC requires Amneal and Impax to divest rights to 10 generic drugs
snippet: 

The U.S. Federal Trade Commission said on Friday it would require Impax Laboratories Inc and privately held Amneal Pharmaceuticals LLC to divest rights to 10 generic medications as a condition of their merger.

Do Not Allow Advertisers to Use My Personal information